X
Please Wait
Applying Filters...
01 SANOFI AVENTIS US (3)
01 TABLET;ORAL (3)
01 RX (3)
01 AMARYL (3)
01 Yes (3)
INS 2024
Not Confirmed
Contact SupplierINS 2024
Not Confirmed
Contact SupplierINS 2024
Not Confirmed
Contact Supplier19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is GLIMEPIRIDE, with a corresponding application number 20496.
Regulatory Information RX
With a dosage strength 4MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1995-11-30
Therapeutic Equivalence (TE) Code AB
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is GLIMEPIRIDE, with a corresponding application number 20496.
Regulatory Information RX
With a dosage strength 1MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1995-11-30
Therapeutic Equivalence (TE) Code AB
17
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is GLIMEPIRIDE, with a corresponding application number 20496.
Regulatory Information RX
With a dosage strength 2MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1995-11-30
Therapeutic Equivalence (TE) Code AB
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
